Buy Stocks Easy | About Us
April 8, 2020
Buy Stocks Easy | Online Stocks

ABEO


Buy Abeona Therapeutics Inc. Stock (symbol: ABEO) Easy Online

Company Name: Abeona Therapeutics Inc.

Symbol: ABEO

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

ABEO Current Share Price

Today's ABEO ( Abeona Therapeutics Inc. ) opening price: $2.9535

Yesterday's ABEO ( Abeona Therapeutics Inc. ) closing price: $5.0000

Abeona Therapeutics Inc. Stock ( symbol: ABEO ) Price Chart since IPO (2000):

12 Months Abeona Therapeutics Inc. Stock ( symbol: ABEO ) Price Chart

Popular Questions about Abeona Therapeutics Inc. Public Stock ( ABEO )

A: Abeona Therapeutics Inc. stock symbol (also called stock or share ticker) is ABEO

A: Abeona Therapeutics Inc. IPO (Initial Public Offering) took place on 2000

A: Abeona Therapeutics Inc.'s stock (ABEO symbol) price at ther IPO (initial Public Offering) was $2.9535

Q: Is ABEO stock worth buying at the moment?

A: The ABEO stock performance since 2019 are rather disappointing. If you had bought 1 share of Abeona Therapeutics Inc. stock (symbol: ABEO) at the beginning of 2019, at the opening share price of $6.7900, you would be left with exactly $2.9535 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.


Buy Abeona Therapeutics Inc. Stock Easy Online

Abeona Therapeutics Inc. Stock Ticker Price Chart since IPO:





Abeona Therapeutics Inc. Stock Price Yesterday



 


Abeona Therapeutics Inc. Stock Price – Last Week




 


Abeona Therapeutics Inc.ilimoww Stock Price – Last Month




 


Abeona Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957914/0/en/Abeona-Therapeutics-Cleared-to-Initiate-Pivotal-Phase-3-Clinical-Trial-Evaluating-EB-101-Gene-Therapy-for-Recessive-Dystrophic-Epidermolysis-Bullosa.html
                            

                                
Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

                                
                                
FDA removes clinical hold; Company may proceed with VIITAL™ study


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932630/0/en/Abeona-Therapeutics-Announces-Presentations-at-the-27th-European-Society-of-Gene-and-Cell-Therapy-ESGCT-Congress.html
                            

                                
Abeona Therapeutics Announces Presentations at the 27th European Society of Gene and Cell Therapy (ESGCT) Congress

                                
                                
NEW YORK and CLEVELAND, Oct.  21, 2019  (GLOBE NEWSWIRE) -- Abeona ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/15/1929848/0/en/Abeona-Therapeutics-Announces-Publication-of-Positive-Long-Term-Data-from-Phase-1-2a-Clinical-Trial-Evaluating-EB-101-Gene-Therapy-for-Recessive-Dystrophic-Epidermolysis-Bullosa.html
                            

                                
Abeona Therapeutics Announces Publication of Positive Long-Term Data from Phase 1/2a Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

                                
                                
Sustained wound healing and favorable safety profile observed at th...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/499768/are-options-traders-betting-on-a-big-move-in-abeona-therapeutics-abeo-stock
                            

                                
Are Options Traders Betting on a Big Move in Abeona Therapeutics (ABEO) Stock?

                                
                                
Investors need to pay close attention to Abeona Therapeutics (ABEO)...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4284949-abeona-therapeutics-inc-abeo-ceo-joao-siffert-q2-2019-results-earnings-call-transcript
                            

                                
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results - Earnings Call Transcript

                                
                                
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/463235/abeona-therapeutics-abeo-reports-q2-loss-misses-revenue-estimates
                            

                                
Abeona Therapeutics (ABEO) Reports Q2 Loss, Misses Revenue Estimates

                                
                                
Abeona Therapeutics (ABEO) delivered earnings and revenue surprises...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/907927/will-these-falling-knives-rebound-
                            

                                
Will These Falling Knives Rebound?

                                
                                
The following securities are falling knives, meaning their share pr...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/431676/biotech-stock-roundup-amgen-gets-fda-nod-for-kanjinti-regeneron-presents-data
                            

                                
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data

                                
                                
Key highlights of the past week include regulatory approvals, colla...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957914/0/en/Abeona-Therapeutics-Cleared-to-Initiate-Pivotal-Phase-3-Clinical-Trial-Evaluating-EB-101-Gene-Therapy-for-Recessive-Dystrophic-Epidermolysis-Bullosa.html
                            

                                
Abeona Therapeutics Cleared to Initiate Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

                                
                                
FDA removes clinical hold; Company may proceed with VIITAL™ study


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932630/0/en/Abeona-Therapeutics-Announces-Presentations-at-the-27th-European-Society-of-Gene-and-Cell-Therapy-ESGCT-Congress.html
                            

                                
Abeona Therapeutics Announces Presentations at the 27th European Society of Gene and Cell Therapy (ESGCT) Congress

                                
                                
NEW YORK and CLEVELAND, Oct.  21, 2019  (GLOBE NEWSWIRE) -- Abeona ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/15/1929848/0/en/Abeona-Therapeutics-Announces-Publication-of-Positive-Long-Term-Data-from-Phase-1-2a-Clinical-Trial-Evaluating-EB-101-Gene-Therapy-for-Recessive-Dystrophic-Epidermolysis-Bullosa.html
                            

                                
Abeona Therapeutics Announces Publication of Positive Long-Term Data from Phase 1/2a Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

                                
                                
Sustained wound healing and favorable safety profile observed at th...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/499768/are-options-traders-betting-on-a-big-move-in-abeona-therapeutics-abeo-stock
                            

                                
Are Options Traders Betting on a Big Move in Abeona Therapeutics (ABEO) Stock?

                                
                                
Investors need to pay close attention to Abeona Therapeutics (ABEO)...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4284949-abeona-therapeutics-inc-abeo-ceo-joao-siffert-q2-2019-results-earnings-call-transcript
                            

                                
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results - Earnings Call Transcript

                                
                                
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q2 2019 Results...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/463235/abeona-therapeutics-abeo-reports-q2-loss-misses-revenue-estimates
                            

                                
Abeona Therapeutics (ABEO) Reports Q2 Loss, Misses Revenue Estimates

                                
                                
Abeona Therapeutics (ABEO) delivered earnings and revenue surprises...


                            

                        
                    

                


                            

                    


                        
                            http://www.gurufocus.com/news/907927/will-these-falling-knives-rebound-
                            

                                
Will These Falling Knives Rebound?

                                
                                
The following securities are falling knives, meaning their share pr...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/431676/biotech-stock-roundup-amgen-gets-fda-nod-for-kanjinti-regeneron-presents-data
                            

                                
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents Data

                                
                                
Key highlights of the past week include regulatory approvals, colla...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.